Month: December 2020

Dr. Kazukani Hayashi’s research team at Cedars-Sinai has recently shown that taking both Gemcitabine (a chemotherapy drug) and Celebrex (an anti-inflammatory drug) together triggers an immune response that increases the efficacy of the chemotherapy drug. Said drug is primarily used

Dr. Jiang in the Sloan Kettering Institute has recently published a paper in Proceedings in the National Academy of Sciences (PNAS) showing that inducing ferroptosis (death by iron) by blocking the PI3K-AKT-mTOR metabolic pathway can kill cancer cells. Here’s the